Evaluation of localized and systemic immune responses in cutaneous leishmaniasis caused by Leishmania tropica: interleukin-8, monocyte chemotactic protein-1 and nitric oxide are major regulatory factors. (73/139)

 (+info)

Therapeutic glucocorticoid-induced TNF receptor-mediated amplification of CD4+ T cell responses enhances antiparasitic immunity. (74/139)

 (+info)

Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). (75/139)

 (+info)

A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis. (76/139)

 (+info)

A randomized controlled trial of local heat therapy versus intravenous sodium stibogluconate for the treatment of cutaneous Leishmania major infection. (77/139)

 (+info)

Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation. (78/139)

 (+info)

Flow cytometric screening for anti-leishmanials in a human macrophage cell line. (79/139)

 (+info)

Regulatory role of nitric oxide in the reduced survival of erythrocytes in visceral leishmaniasis. (80/139)

 (+info)